À retenir
Across 133 randomised trials with 12 197 participants, each 50 mmol reduction in 24-hour sodium excretion was linked to a 1.10 mm Hg fall in systolic blood pressure, with larger drops in older people and those with higher starting pressure. Trials under 15 days showed less than half the effect of longer ones.
Study design
Méta-analyse d’essais
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Guidelines recommend less salt, but how much blood pressure falls for a given sodium cut, and whether it depends on how long people stay on a low-sodium diet, was unclear. The authors tested the dose-response relation between sodium reduction and blood pressure change and whether trial duration matters.
Population et méthode
Systematic review and meta-analysis following PRISMA guidelines. They searched Ovid MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials up to 21 January 2019 for randomised trials in adults comparing different sodium intakes, with intake estimated by 24 hour urinary sodium excretion. Two of three reviewers screened records, one extracted data and the others checked it. Random effects meta-analyses, subgroup analyses and meta-regression were used. Registered in PROSPERO (CRD42019140812).
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Reduced-sodium groups had a mean 130 mmol lower 24-hour urinary sodium (95% CI 115 to 145, P<0.001) than usual-sodium groups, with systolic blood pressure (SBP) lower by 4.26 mm Hg (3.62 to 4.89, P<0.001) and diastolic (DBP) by 2.07 mm Hg (1.67 to 2.48, P<0.001).
- 2Each 50 mmol reduction in 24-hour sodium excretion was associated with a 1.10 mm Hg (0.66 to 1.54; P<0.001) fall in SBP and a 0.33 mm Hg (0.04 to 0.63; P=0.03) fall in DBP.
- 3Pressure fell in both hypertensive and non-hypertensive people. For the same sodium cut, the SBP fall was greater in older people, non-white populations and those with higher baseline SBP.
- 4In trials under 15 days, each 50 mmol reduction gave a 1.05 mm Hg SBP fall (0.40 to 1.70; P=0.002), less than half the 2.13 mm Hg (0.85 to 3.40; P=0.002) seen in longer trials. Otherwise, trial duration was not associated with SBP reduction.
Limites et incertitude
- 1Meta-analysis of trials that differ in design, populations and sodium targets; the abstract does not report heterogeneity or risk of bias.
- 2Blood pressure is a surrogate outcome; the abstract does not report effects on heart attacks, strokes or death.
- 3Subgroup differences by age, ethnicity and baseline pressure come from meta-regression across trials, not from comparisons within trials. This reading is based on the abstract only.
Mise en perspective
A lower-sodium diet reliably lowers blood pressure a little, more so in people who are older or have higher readings, and the benefit seems to build over a longer period. These are average effects across trials, not a personal prediction. Anyone on blood pressure medication or with a heart or kidney condition should discuss diet changes with a clinician.
Vos données
A home blood pressure cuff is the most direct way to see this. Measure at the same time of day, seated and rested, and compare weekly averages before and after a diet change instead of single readings. A food log can estimate sodium intake, but labels and restaurant meals make it rough.
Comprendre ce type de preuve
Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Objective
To examine the dose-response relation between reduction in dietary sodium and blood pressure change and to explore the impact of intervention duration.
Design
Systematic review and meta-analysis following PRISMA guidelines.
Data sources
Ovid MEDLINE(R), EMBASE, and Cochrane Central Register of Controlled Trials (Wiley) and reference lists of relevant articles up to 21 January 2019.
Inclusion criteria
Randomised trials comparing different levels of sodium intake undertaken among adult populations with estimates of intake made using 24 hour urinary sodium excretion.
Data extraction and analysis
Two of three reviewers screened the records independently for eligibility. One reviewer extracted all data and the other two reviewed the data for accuracy. Reviewers performed random effects meta-analyses, subgroup analyses, and meta-regression.
Results
133 studies with 12 197 participants were included. The mean reductions (reduced sodium v usual sodium) of 24 hour urinary sodium, systolic blood pressure (SBP), and diastolic blood pressure (DBP) were 130 mmol (95% confidence interval 115 to 145, P<0.001), 4.26 mm Hg (3.62 to 4.89, P<0.001), and 2.07 mm Hg (1.67 to 2.48, P<0.001), respectively. Each 50 mmol reduction in 24 hour sodium excretion was associated with a 1.10 mm Hg (0.66 to 1.54; P<0.001) reduction in SBP and a 0.33 mm Hg (0.04 to 0.63; P=0.03) reduction in DBP. Reductions in blood pressure were observed in diverse population subsets examined, including hypertensive and non-hypertensive individuals. For the same reduction in 24 hour urinary sodium there was greater SBP reduction in older people, non-white populations, and those with higher baseline SBP levels. In trials of less than 15 days' duration, each 50 mmol reduction in 24 hour urinary sodium excretion was associated with a 1.05 mm Hg (0.40 to 1.70; P=0.002) SBP fall, less than half the effect observed in studies of longer duration (2.13 mm Hg; 0.85 to 3.40; P=0.002). Otherwise, there was no association between trial duration and SBP reduction.
Conclusions
The magnitude of blood pressure lowering achieved with sodium reduction showed a dose-response relation and was greater for older populations, non-white populations, and those with higher blood pressure. Short term studies underestimate the effect of sodium reduction on blood pressure.
Systematic review registration
PROSPERO CRD42019140812.
Sources et attribution
Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials.
Huang L, Trieu K, Yoshimura S, Neal B, Woodward M, Campbell NRC, Li Q, Lackland DT, Leung AA, Anderson CAM, MacGregor GA, He FJ.
BMJ (Clinical research ed.) · 2020-02-24
DOI: 10.1136/bmj.m315 ↗PubMed · 32094151 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

